Rapid Micro Biosystems, Inc.
RPID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $39,218 | $31,838 | $47,973 | $441,213 |
| - Cash | $16,911 | $24,285 | $27,064 | $178,387 |
| + Debt | $6,168 | $7,346 | $7,968 | $400 |
| Enterprise Value | $28,475 | $14,899 | $28,877 | $263,226 |
| Revenue | $28,051 | $22,519 | $17,133 | $23,232 |
| % Growth | 24.6% | 31.4% | -26.3% | – |
| Gross Profit | -$109 | -$5,485 | -$8,540 | -$7,741 |
| % Margin | -0.4% | -24.4% | -49.8% | -33.3% |
| EBITDA | -$46,557 | -$53,458 | -$60,382 | -$45,703 |
| % Margin | -166% | -237.4% | -352.4% | -196.7% |
| Net Income | -$46,889 | -$52,467 | -$60,806 | -$73,524 |
| % Margin | -167.2% | -233% | -354.9% | -316.5% |
| EPS Diluted | -1.08 | -1.22 | -1.43 | -1.88 |
| % Growth | 11.5% | 14.7% | 23.9% | – |
| Operating Cash Flow | -$44,153 | -$45,081 | -$58,547 | -$54,964 |
| Capital Expenditures | -$1,365 | -$1,845 | -$6,740 | -$3,217 |
| Free Cash Flow | -$45,518 | -$46,926 | -$65,287 | -$58,181 |